SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (3172)12/6/1997 10:54:00 PM
From: JOHN W.  Respond to of 6136
 
I think it is very important to review the post by those that would like to beat down this stock, they were trying to beat it down with the same tired arguments earlier this year . When AGPH reached over 100 during the approval time, then a few months later it bottomed down at 58, they were screaming, I told you so, Sell now.

I am sure several people may have done just that and then a few months later after the stock split, recovered to new highs at 113 (56 1/2-post split)..Don't make the same mistake.



To: Izzy who wrote (3172)12/8/1997 10:43:00 AM
From: tommysdad  Read Replies (1) | Respond to of 6136
 
You would likely not be impressed if you were to visit AGPH with AMGN's facilities in your mind. Like most biotechs in San Diego, they rent the space and things are kind of cramped -- lots of small offices and your average (not prettifed for investors) labs. They're spending their money on other things right now . . . In many ways, the part of their facilities I've been to looks like an academic lab.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News